glp-1 side effects anxiety Semaglutide & Mental Health GLP-1 nausea: How to handle

The AOD designation stands for Anti-Obesity Drug, reflecting the original research focus of the compounds development

Up-and-coming medications such as Retatrutide and Cagrilintide are on the horizon, indicating a potential shift in treating obesity and managing diabetes

These studies highlight the importance of continued treatment for sustained success

Ozempic Face Isnt Unique to GLP-1s The term Ozempic face describes the facial changes that accompany rapid weight loss, but this phenomenon isnt caused by any specific medication

This makes them more accessible despite an ongoing shortage among brand-name GLP-1 RAs

Whilst GLP-1 receptor agonists are not licensed for treating inflammatory diseases, emerging clinical evidence suggests potential benefits in several conditions characterised by chronic inflammation